Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

Coadministration of long-acting GSK-744 and rilpivirine found feasible

July 8, 2013

Results from phase III trials of dolutegravir presented

July 5, 2013

In vitro and in vivo anti-HIV activity of a novel HIV-1 splicing inhibitor

July 4, 2013

Janssen presents bioequivalence results for darunavir/cobicistat fixed-drug combination

July 3, 2013

Bionor Pharma obtains GLOBVAC grant to advance research on Vacc-HIV

June 25, 2013

AiCuris patents novel reverse transcriptase inhibitors for HIV infection

June 25, 2013

Bionor Pharma completes first part of phase II study combining Vacc-4x with Revlimid

June 14, 2013

Amrita Therapeutics discloses novel antiviral proteins

June 14, 2013

Chinese researchers patent novel HIV fusion inhibitors

June 13, 2013

Calimmune presents preclinical results for its anti-HIV lentiviral vector gene therapy

May 31, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Regulatory actions for July 27, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...